Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial.
Galactionova K, Loibl S, Salari P, Marmé F, Martin M, Untch M, Bonnefoi HR, Kim SB, Bear HD, McCarthy N, Gelmon KA, García-Sáenz JA, Kelly CM, Reimer T, Toi M, Rugo HS, Gnant M, Makris A, Burchardi N, Schwenkglenks M. Galactionova K, et al. Among authors: schwenkglenks m. Front Oncol. 2022 Sep 5;12:886831. doi: 10.3389/fonc.2022.886831. eCollection 2022. Front Oncol. 2022. PMID: 36132153 Free PMC article.
Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis.
Loibl S, Skacel T, Nekljudova V, Lück HJ, Schwenkglenks M, Brodowicz T, Zielinski C, von Minckwitz G. Loibl S, et al. Among authors: schwenkglenks m. BMC Cancer. 2011 Apr 12;11:131. doi: 10.1186/1471-2407-11-131. BMC Cancer. 2011. PMID: 21486442 Free PMC article. Clinical Trial.
Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A, Kind P, Salari P, Jungo KT, Boland B, Byrne S, Hossmann S, Dalleur O, Knol W, Moutzouri E, O'Mahony D, Murphy KD, Wisselink L, Rodondi N, Schwenkglenks M. Bhadhuri A, et al. Among authors: schwenkglenks m. Health Qual Life Outcomes. 2020 Sep 29;18(1):317. doi: 10.1186/s12955-020-01564-0. Health Qual Life Outcomes. 2020. PMID: 32993637 Free PMC article. Clinical Trial.
Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study.
Salari P, O'Mahony C, Henrard S, Welsing P, Bhadhuri A, Schur N, Roumet M, Beglinger S, Beck T, Jungo KT, Byrne S, Hossmann S, Knol W, O'Mahony D, Spinewine A, Rodondi N, Schwenkglenks M. Salari P, et al. Among authors: schwenkglenks m. PLoS One. 2022 Apr 11;17(4):e0265507. doi: 10.1371/journal.pone.0265507. eCollection 2022. PLoS One. 2022. PMID: 35404990 Free PMC article. Clinical Trial.
Healthcare Costs and Health-Related Quality of Life in Older Multimorbid Patients After Hospitalization.
Salari P, Henrard S, O'Mahony C, Welsing P, Bhadhuri A, Jungo KT, Beck T, O'Mahony D, Byrne S, Spinewine A, Knol W, Rodondi N, Schwenkglenks M. Salari P, et al. Among authors: schwenkglenks m. Health Serv Insights. 2023 Feb 5;16:11786329231153278. doi: 10.1177/11786329231153278. eCollection 2023. Health Serv Insights. 2023. PMID: 36760460 Free PMC article.
Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).
Claude J, Schindler C, Kuster GM, Schwenkglenks M, Szucs T, Buser P, Osswald S, Kaiser C, Grädel C, Estlinbaum W, Rickenbacher P, Pfisterer M; Trial of Invasive versus Medical therapy in the Elderly (TIME) Investigators. Claude J, et al. Among authors: schwenkglenks m. Eur Heart J. 2004 Dec;25(24):2195-203. doi: 10.1016/j.ehj.2004.09.013. Eur Heart J. 2004. PMID: 15589636 Clinical Trial.
233 results